Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population‐based cohort study

To estimate prevalence of continuous use (persistence) of prescribed cannabinoid medications for up to 1 year from initial prescription in Manitoba, Canada and predictors of duration of use.A retrospective, population-based, cohort study using administrative data from the Manitoba Population Research Data Repository located at the Manitoba Centre for Health Policy, Canada.People without a record of a previous prescription who were prescribed a...